Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Adolesc Health. 2018 Nov 2;64(3):355–361. doi: 10.1016/j.jadohealth.2018.09.003

Table 1.

Unadjusted participant characteristics at baseline and follow-ups by treatment sequence

Phase 1 treatment Group

Home Office

Age, M (SD) years 13.64 (1.29) 13.86 (1.41)
Gender, N (%) girls 67 (74.4%) 55 (60.4%)
T1 executive functioning, M (SD) 123.10 (26.12) 124.4 (29.30)
T1 weight, M (SD) pounds 223.04 (47.88) 236.81 (53.55)
T1 confidence, M (SD) 6.62 (1.70) 7.13 (1.69)
T1 BMI, M (SD) kg/m2 37.46 (7.13) 38.84 (7.73)
T1 percent overweight, M (SD) 93.75 (36.10) 99.83 (38.97)
P1 session attendance, M (SD) 13.17 (5.68) 8.62 (5.73)
T2 skills utilization, M (SD) 3.30 (0.68) 3.06 (0.74)
Phase 2 treatment group*
CM CS RP CM CS RP

T2 percent overweight, M (SD) 95.48 (38.47) 92.27 (40.27) 74.38 (28.53) 103.52 (44.52) 98.63 (36.78) 93.34 (36.72)
P2 session attendance, M (SD) 17.71 (6.75) 8.65 (6.08) 7.95 (3.20) 13.35 (8.47) 7.68 (5.86) 3.00 (3.90)
T3 skills utilization, M (SD) 3.25 (0.75) 2.84 (0.74) 3.16 (0.87) 2.96 (0.79) 2.90 (0.74) 2.46 (0.76)

Notes: CM = contingency management; CS = continued skills; RP = relapse prevention.

T1 = baseline. T2 = 3-month follow-up (end of Phase 1 [P1]). T3 = 7-month follow-up (end of Phase 2 [P2]).

*

Although CM and CS both took place in participants’ homes, the 6 Phase 2 groups are shown here below the Phase 1 group in which they started (i.e., the second CM column represents teens who were first assigned to Office then to CM).